elzasonan

elzasonan Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Elzasonan is a selective 5-hydroxytryptamine 1B receptor antagonist that was developed by Pfizer (and then later discontinued in 2008) to treat patients with major depressive disorder and obsessive compulsive disorder.

elzasonan Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

elzasonan Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Energy Chemical	021-58432009 400-005-6266	marketing@energy-chemical.com	China	44941	58
Suzhou Meishi Biotechnology Co., Ltd.	1173954148q	meishipharma@126.com	China	20035	58
TargetMol Chemicals Inc.	15002134094	marketing@targetmol.cn	China	28091	58

---

• (2Z)-4-(3,4-dichlorophenyl)-2-[[2-(4-methylpiperazin-1-yl)phenyl]methylidene]thiomorpholin-3-one
• 361343-19-3